نتایج جستجو برای: nanoemulsifying drug delivery systems

تعداد نتایج: 1857889  

Journal: :Pharmaceutical Development and Technology 2018

Journal: :Drug development & registration 2021

Journal: :Journal of Pharmaceutics 2014

Journal: :Bioengineering & Translational Medicine 2016

Journal: :jundishapur journal of natural pharmaceutical products 0
abbas akhgari department of pharmaceutics, nanotechnology research center and school of pharmacy, ahvaz jundishapur university of medical sciences, ahvaz, ir iran; nanotechnology research center and school of pharmacy, ahvaz jundishapur university of medical sciences, ahvaz, ir iran. tel: +98-6133738380

Journal: :iranian journal of pharmaceutical sciences 0
samira sadat abolmaali department of pharmaceutics, faculty of pharmacy, and pharmaceutical sciences research center, shiraz university of medical sciences, shiraz, iran ali mohammad tamaddon department of pharmaceutics, faculty of pharmacy, and pharmaceutical sciences research center, shiraz university of medical sciences, shiraz, iran fakhr sadat farvadi department of pharmaceutics, faculty of pharmacy, and pharmaceutical sciences research center, shiraz university of medical sciences, shiraz, iran saeed daneshamuz department of pharmaceutics, faculty of pharmacy, and pharmaceutical sciences research center, shiraz university of medical sciences, shiraz, iran hamidreza moghimi department of pharmaceutics, faculty of pharmacy, shaheed beheshti university of medical sciences, tehran, iran

topical and transdermal drug delivery systems are noninvasive and can be self-administered with the minimization of side-effects, have received increased attention during the past few years. nanoemulsions, emulsions sized between 20-200 nm with narrow distributions, offer several advantages for topical and transdermal delivery of pharmaceutical agents including controlled droplet size, the abil...

Journal: Journal of Nanoanalysis 2018

This review focuses on the extensive study of different layered double hydroxides (LDHs)nanostructures and also their biological and physicochemical (in vitro) properties to encapsulateand deliver drugs with a recognized pharmacokinetic profile in a sustained/modified manner forbetter remedial efficacy contrasted to the corresponding conventional treatments using different<br ...

Dasatinib is a tyrosine kinase inhibitor (TKI) that is used to treat chronic myeloid leukemia and in the management of ulcerative colitis (UC) and to provide appropriate results in treatment. Dasatinib is significantly higher and faster than full cytogenetic and large molecular responses as compared to imatinib. In the recent study, using the NMR data, the frequency and thermochemical propertie...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید